JPH0965891A - Production of optically active alpha-methylalkanoic acid derivative - Google Patents

Production of optically active alpha-methylalkanoic acid derivative

Info

Publication number
JPH0965891A
JPH0965891A JP21894195A JP21894195A JPH0965891A JP H0965891 A JPH0965891 A JP H0965891A JP 21894195 A JP21894195 A JP 21894195A JP 21894195 A JP21894195 A JP 21894195A JP H0965891 A JPH0965891 A JP H0965891A
Authority
JP
Japan
Prior art keywords
optically active
ester
methylalkanoic
methylalkanoic acid
microorganism
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP21894195A
Other languages
Japanese (ja)
Inventor
Eiji Ozaki
英司 尾崎
Toshitaka Uragaki
俊孝 浦垣
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsubishi Rayon Co Ltd
Original Assignee
Mitsubishi Rayon Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsubishi Rayon Co Ltd filed Critical Mitsubishi Rayon Co Ltd
Priority to JP21894195A priority Critical patent/JPH0965891A/en
Publication of JPH0965891A publication Critical patent/JPH0965891A/en
Pending legal-status Critical Current

Links

Landscapes

  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

PROBLEM TO BE SOLVED: To produce an optically active α-methylalkanoic acid to be used as a raw material for production of various liquid crystals or as an intermediate for synthesizing optically active medicines and agrochemicals by making microorganisms having ability to asymmetrically hydrolyze ester linkage act on a racemic α-methylalkanoic ester. SOLUTION: The objective optically active derivative to be used as a raw material for production of various liquid crystals or as an intermediate for synthesis of optically active medicines and agrochemicals is effectively produced position-selectively by making a cultured product, microbial bodies or microbial body-treated product of microorganisms [e.g. Escherichia coli MR-2103 (FERM BP-3835)] which have ability to asymmetrically hydrolyze ester linkages act on a racemic α-metylalkanoic ester of formula I (R is a 1-6C alkyl ; n is an integer of 1-3) (e.g. racemic methyl α-methylhexanoate) to produce an optically active α-methylalkanoic acid of formula II (C* is an asymmetric carbon atom) and/or an antipode ester of the optically active α-methylalkanoic acid of formula III, and then by separating the product ester.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【発明の属する技術分野】本発明は、種々の液晶原料又
は光学活性医農薬の合成中間体として有用な下記の一般
式(II)で表される光学活性α−メチルアルカン酸、及
び/又は下記の一般式(III)で表される光学活性α−
メチルアルカン酸の対掌体エステルの製造方法に関す
る。
TECHNICAL FIELD The present invention relates to an optically active α-methylalkanoic acid represented by the following general formula (II), which is useful as a synthetic intermediate for various liquid crystal raw materials or optically active pharmaceuticals and agricultural chemicals, and / or Of the optically active α- represented by the general formula (III)
The present invention relates to a method for producing an enantiomer ester of methylalkanoic acid.

【0002】[0002]

【化4】 Embedded image

【0003】[0003]

【化5】 Embedded image

【0004】[0004]

【従来の技術】一般式(II):PRIOR ART General formula (II):

【0005】[0005]

【化6】 [Chemical 6]

【0006】又は一般式(III):Or general formula (III):

【0007】[0007]

【化7】 [Chemical 7]

【0008】で表される光学活性α−メチルアルカン酸
誘導体のなかで例えば光学活性α−メチルヘキサン酸エ
ステルについて、α−メチルヘキサン酸をリパーゼを用
いて立体選択的にエステル化する方法が報告されている
(E.K.Heinz, Tetrahedron:Asymmetry, 2(3), 165-168
(1991))。 しかしながら、工業生産を考えた場合、収
率、光学純度共に満足できるものではない。
Among the optically active α-methylalkanoic acid derivatives represented by, for example, for optically active α-methylhexanoic acid ester, a method of esterifying α-methylhexanoic acid stereoselectively using lipase has been reported. (EKHeinz, Tetrahedron: Asymmetry, 2 (3), 165-168
(1991)). However, considering industrial production, neither the yield nor the optical purity is satisfactory.

【0009】[0009]

【発明が解決しようとする課題】本発明の目的は、種々
の液晶原料又は光学活性医農薬の合成中間体としての用
途が期待される光学純度の高い前記一般式(II)で表さ
れる光学活性α−メチルアルカン酸及び一般式(III)
で表される光学活性α−メチルアルカン酸の対掌体エス
テルを高い光学純度で位置選択的に効率よく製造する方
法を提供することにある。
The object of the present invention is to provide an optical compound represented by the above general formula (II) having a high optical purity which is expected to be used as a synthetic intermediate for various liquid crystal raw materials or optically active pharmaceutical and agricultural chemicals. Active α-methylalkanoic acid and general formula (III)
Another object of the present invention is to provide a method for efficiently and regioselectively producing an enantiomer ester of an optically active α-methylalkanoic acid represented by

【0010】[0010]

【課題を解決するための手段】即ち、本発明は、下記の
一般式(I):
That is, the present invention provides the following general formula (I):

【0011】[0011]

【化8】 Embedded image

【0012】(式中、Rは炭素数1〜6のアルキル基を
示し、nは1〜3の整数を示す。)で表されるラセミ体
α−メチルアルカン酸エステルに、エステル結合を不斉
加水分解する能力を有する微生物の培養物、菌体又は菌
体処理物を作用させて下記の一般式(II):
(Wherein R represents an alkyl group having 1 to 6 carbon atoms and n represents an integer of 1 to 3), the ester bond is asymmetrical to the racemic α-methylalkanoic acid ester. The following general formula (II) is obtained by reacting a culture of a microorganism having the ability to hydrolyze, a bacterial cell or a treated product of the bacterial cell:

【0013】[0013]

【化9】 Embedded image

【0014】で表される光学活性α−メチルアルカン
酸、及び/又は下記の一般式(III):
An optically active α-methylalkanoic acid represented by: and / or the following general formula (III):

【0015】[0015]

【化10】 Embedded image

【0016】で表される、前記光学活性α−メチルアル
カン酸の対掌体エステルを製造する方法にある。
A method for producing the enantiomer ester of the optically active α-methylalkanoic acid represented by

【0017】本発明において、前記式中、Rは酵素反応
の基質となるようなものであればどのようなものでもよ
いが、例えばメチル基、エチル基、プロピル基、イソプ
ロピル基、ブチル基、イソブチル基等が例示できる。
In the present invention, R in the above formula may be any as long as it serves as a substrate for an enzymatic reaction, and examples thereof include methyl group, ethyl group, propyl group, isopropyl group, butyl group and isobutyl. Examples thereof include groups.

【0018】本発明で用いる微生物は、前記一般式
(I)で表されるラセミ体α−メチルアルカン酸エステ
ルのエステル結合を不斉加水分解し、光学活性α−メチ
ルアルカン酸及びその対掌体エステルを生産する能力を
有するものであればどのようなものも使用可能である。
代表的なものとして、シュードモナス(Pseudomonas)
属、エセリキア(Escherichia)属に属する微生物が挙げ
られる。具体的にはシュードモナス・プチダ(Pseudomon
as putida)MR-2068(FERM BP-3846)、エセリキア・コリ
(Escherichia coli)MR-2103(FERM BP-3835)が挙げられ
る。エセリキア・コリ(Escherichia coli)MR-2103(FERM
BP-3835)は、シュードモナス・プチダ(Pseudomonas pu
tida)MR-2068(FERM BP-3846)由来のエステラーゼ遺伝子
で形質転換された株である。
The microorganism used in the present invention asymmetrically hydrolyzes the ester bond of the racemic α-methylalkanoic acid ester represented by the general formula (I) to give an optically active α-methylalkanoic acid and its enantiomer. Anything that has the ability to produce an ester can be used.
As a representative, Pseudomonas
Examples include microorganisms belonging to the genus Escherichia. Specifically, Pseudomonas
as putida) MR-2068 (FERM BP-3846), Esericia coli
(Escherichia coli) MR-2103 (FERM BP-3835). Escherichia coli MR-2103 (FERM
BP-3835) is a Pseudomonas pu
tida) MR-2068 (FERM BP-3846) -derived esterase gene-transformed strain.

【0019】本発明で用いる微生物の培養は、液体培地
でも固体培地でも行うことができる。培地としては、微
生物が通常資化しうる炭素源、窒素源、ビタミン、ミネ
ラル等の成分を適宜配合したものが用いられる。微生物
の加水分解能を向上させるため、培地にエステルを少量
添加することも可能である。培養は微生物が生育可能で
ある温度、pHで行われるが、使用する菌株の最適培養
条件で行うことが好ましい。微生物の生育を促進させる
ため、通気攪拌を行ってもよい。
The culture of the microorganism used in the present invention can be carried out in a liquid medium or a solid medium. As the medium, a medium appropriately mixed with components such as a carbon source, a nitrogen source, vitamins, and minerals that can normally be used by microorganisms is used. It is also possible to add a small amount of ester to the medium in order to improve the ability of the microorganism to hydrolyze. The culture is carried out at a temperature and pH at which the microorganism can grow, but it is preferably carried out under the optimum culture conditions of the strain to be used. Aeration and agitation may be performed to promote the growth of microorganisms.

【0020】加水分解反応を行うに際しては、培養の開
始時又は途中で培地にエステルを添加してもよく、予め
微生物を培養した後、培養液にエステルを添加してもよ
い。また増殖した微生物の菌体を遠心分離等により採取
し、これをエステルを含む反応媒体に加えてもよい。菌
体としては、アセトン、トルエン等で処理した菌体を用
いてもよい。
When carrying out the hydrolysis reaction, the ester may be added to the medium at the start or during the culture, or the ester may be added to the culture solution after culturing the microorganism in advance. Alternatively, the cells of the grown microorganism may be collected by centrifugation or the like and added to the reaction medium containing the ester. As the bacterial cells, bacterial cells treated with acetone, toluene or the like may be used.

【0021】また、菌体の代わりに、培養液等の培養
物、菌体破砕物、菌体抽出物、粗酵素、精製酵素等の菌
体処理物を用いてもよく、更に、酵素又は微生物を適当
な担体に固定化し、反応を行った後に回収再利用するこ
とも可能である。ここで、酵素としては微生物由来の各
種リパーゼ、プロアテーゼ及びエステラーゼが使用可能
である。
Further, instead of the cells, a culture such as a culture solution, a cell disruption product, a cell extract, a crude enzyme, a purified enzyme or the like treated cell may be used. It is also possible to immobilize on a suitable carrier, carry out the reaction, and then collect and reuse. Here, as the enzyme, various lipases, proteases and esterases derived from microorganisms can be used.

【0022】反応媒体としては、例えばイオン交換水、
緩衝液が用いられる。反応媒体又は培養液中のエステル
濃度としては、0.1〜70重量%が好ましいが、更に
好ましくは5〜40%である。メタノール、アセトン、
界面活性剤等を反応系に添加することも可能である。反
応液のpHは、2〜11、好ましくは5〜8の範囲であ
る。反応が進行するに従い生成したカルボン酸により反
応液のpHが低下してくるが、この場合は適当な中和剤
で最適pHに維持することが好ましい。反応温度は5〜
70℃が好ましく、10〜60℃が更に好ましい。
As the reaction medium, for example, ion-exchanged water,
A buffer is used. The ester concentration in the reaction medium or culture medium is preferably 0.1 to 70% by weight, more preferably 5 to 40%. Methanol, acetone,
It is also possible to add a surfactant or the like to the reaction system. The pH of the reaction solution is in the range of 2 to 11, preferably 5 to 8. As the reaction progresses, the pH of the reaction solution decreases due to the carboxylic acid formed. In this case, it is preferable to maintain the pH at an optimum level with a suitable neutralizing agent. The reaction temperature is 5
70 degreeC is preferable and 10-60 degreeC is more preferable.

【0023】反応終了液からの生産物の分離精製は、酢
酸エチル、クロロホルム、ジエチルエーテル等の有機溶
媒による抽出を行い、次いで蒸留あるいはカラムクロマ
トグラフィー等の通常の精製法を適用することにより、
光学活性α−メチルアルカン酸エステルを精製、取得す
ることができる。抽出後の水層のpHを2以下に下げる
ことにより、その対掌体である光学活性α−メチルアル
カン酸を遊離酸とした後、有機溶媒、例えば酢酸エチル
で抽出すれば光学活性α−メチルアルカン酸を回収でき
る。
Separation and purification of the product from the reaction-terminated liquid is carried out by extraction with an organic solvent such as ethyl acetate, chloroform, diethyl ether and the like, and then applying a usual purification method such as distillation or column chromatography.
An optically active α-methylalkanoic acid ester can be purified and obtained. By lowering the pH of the aqueous layer after extraction to 2 or less, the antipodal optically active α-methylalkanoic acid is converted into a free acid, and then extracted with an organic solvent such as ethyl acetate to obtain the optically active α-methylalkanoic acid. The alkanoic acid can be recovered.

【0024】以上のようにして得られる光学活性α−メ
チルアルカン酸エステルは、常法に従ってラセミ化しな
いような条件下で加水分解することにより、立体配置を
保持したまま光学活性α−メチルアルカン酸に変換する
ことができ、また光学活性α−メチルアルカン酸は、常
法に従ってラセミ化しないような条件下でエステル化す
ることにより、立体配置を保持したまま光学活性α−メ
チルアルカン酸エステルに変換することができる。
The optically active α-methylalkanoic acid ester obtained as described above is hydrolyzed according to a conventional method under conditions such that racemization does not occur, so that the optically active α-methylalkanoic acid ester retains its configuration. Further, the optically active α-methylalkanoic acid can be converted into an optically active α-methylalkanoic acid ester while maintaining the configuration by esterification under conditions that do not cause racemization according to a conventional method. can do.

【0025】[0025]

【実施例】以下、本発明を実施例により更に詳しく説明
するが、これらに限定されるものではない。
EXAMPLES The present invention will be described in more detail with reference to examples below, but the invention is not limited thereto.

【0026】[実施例1]光学活性α−メチルヘキサン
酸及びその対掌体エステルの製造 エセリキア・コリ(Escherichia coli)MR-2103(FERM BP-
3835)を50μg/mlのアンピシリンを含むLB培地
(1%ポリペプトン、0.5%酵母エキス、0.5%N
aCl)50mlに植菌し、37℃、20時間振盪培養
した。培養終了後、培養液を遠心分離し、得られた菌体
の全量をイオン交換水で洗浄した後、50mM燐酸緩衝
液(pH7.0)50mlに懸濁した。この菌体懸濁液
に、ラセミ体−α−メチルヘキサン酸メチル5gを加
え、30℃で20時間反応させた。この間、反応液のp
Hは、1N NaOH水溶液を用いて7.0に調整し
た。反応終了後、遠心分離により菌体を除き、未反応の
α−メチルヘキサン酸メチルを酢酸エチルで抽出した。
有機層に無水硫酸ナトリウムを加えて脱水し、溶媒を蒸
発除去し、更に蒸留精製し、1.9gの光学活性α−メ
チルヘキサン酸メチルを得た。 この光学活性α−メチ
ルヘキサン酸メチルの比旋光度を測定したところ、
[α]25 D=+16.3であった。
[Example 1] Production of optically active α-methylhexanoic acid and its enantiomer ester Escherichia coli MR-2103 (FERM BP-
3835) in LB medium containing 50 μg / ml of ampicillin (1% polypeptone, 0.5% yeast extract, 0.5% N).
(aCl) was inoculated into 50 ml and cultured with shaking at 37 ° C. for 20 hours. After completion of the culture, the culture solution was centrifuged, the whole amount of the obtained bacterial cells was washed with ion-exchanged water, and then suspended in 50 ml of 50 mM phosphate buffer (pH 7.0). To this cell suspension, 5 g of racemic methyl-α-methylhexanoate was added, and the mixture was reacted at 30 ° C for 20 hours. During this period, p of the reaction solution
H was adjusted to 7.0 using a 1N NaOH aqueous solution. After completion of the reaction, cells were removed by centrifugation and unreacted methyl α-methylhexanoate was extracted with ethyl acetate.
Anhydrous sodium sulfate was added to the organic layer for dehydration, the solvent was removed by evaporation, and the residue was further purified by distillation to obtain 1.9 g of optically active methyl α-methylhexanoate. When the specific optical rotation of this optically active methyl α-methylhexanoate was measured,
[Α] 25 D was +16.3.

【0027】次いで水相のpHを希硫酸で2.0に下げ
た後、水相中の酸分を酢酸エチルで抽出した。有機層に
無水硫酸ナトリウムを加えて脱水し、溶媒を蒸発除去
し、更に蒸留精製し、1.3gの光学活性α−メチルヘ
キサン酸を得た。このサンプルの比旋光度を測定したと
ころ、[α]25 D=−16.3であった。
Next, the pH of the aqueous phase was lowered to 2.0 with diluted sulfuric acid, and the acid content in the aqueous phase was extracted with ethyl acetate. Anhydrous sodium sulfate was added to the organic layer for dehydration, the solvent was removed by evaporation, and the residue was further purified by distillation to obtain 1.3 g of optically active α-methylhexanoic acid. When the specific optical rotation of this sample was measured, it was [α] 25 D = -16.3.

【0028】[実施例2]光学活性α−メチルペンタン
酸及びその対掌体エステルの製造 実施例1で得た菌体懸濁液に、ラセミ体−α−メチルペ
ンタン酸メチル5gを加え、30℃で20時間反応させ
た。この間、反応液のpHは、1N NaOH水溶液を
用いて7.0に調整した。反応終了後、遠心分離により
菌体を除き、未反応のα−メチルペンタン酸メチルをヘ
キサンで抽出した。有機層に無水硫酸ナトリウムを加え
て脱水し、溶媒を蒸発除去し、更に蒸留精製し、1.9
gの光学活性α−メチルペンタン酸メチルを得た。
[Example 2] Production of optically active α-methylpentanoic acid and its enantiomer ester To the bacterial cell suspension obtained in Example 1, 5 g of racemic methyl-α-methylpentanoate was added to give 30 The reaction was carried out at 0 ° C for 20 hours. During this period, the pH of the reaction solution was adjusted to 7.0 using a 1N NaOH aqueous solution. After completion of the reaction, cells were removed by centrifugation and unreacted methyl α-methylpentanoate was extracted with hexane. Anhydrous sodium sulfate was added to the organic layer for dehydration, the solvent was removed by evaporation, and the residue was purified by distillation to obtain 1.9.
Thus, g of optically active methyl α-methylpentanoate was obtained.

【0029】この光学活性α−メチルペンタン酸メチル
の比旋光度を測定したところ、[α]25 D=+19.5
であった。
When the specific optical rotation of this optically active methyl α-methylpentanoate was measured, [α] 25 D = + 19.5.
Met.

【0030】次いで水相のpHを希硫酸で2.0に下げ
た後、水相中の酸分を酢酸エチルで抽出した。有機層に
無水硫酸ナトリウムを加えて脱水し、溶媒を蒸発除去
し、更に蒸留精製し、1.3gの光学活性α−メチルペ
ンタン酸を得た。このサンプルの比旋光度を測定したと
ころ、[α]25 D=−16.8であった。
Next, the pH of the aqueous phase was lowered to 2.0 with diluted sulfuric acid, and the acid content in the aqueous phase was extracted with ethyl acetate. Anhydrous sodium sulfate was added to the organic layer for dehydration, the solvent was removed by evaporation, and the residue was further purified by distillation to obtain 1.3 g of optically active α-methylpentanoic acid. When the specific optical rotation of this sample was measured, it was [α] 25 D = -16.8.

【0031】[0031]

【発明の効果】本発明によれば、種々の液晶原料又は光
学活性医農薬の合成中間体としての用途が期待される光
学純度の高い前記一般式(II)で表される光学活性α−
メチルアルカン酸及び一般式(III)で表される光学活
性α−メチルアルカン酸の対掌体エステルを高い光学純
度で位置選択的に効率よく製造することができる。
INDUSTRIAL APPLICABILITY According to the present invention, the optically active α-represented by the above-mentioned general formula (II) having high optical purity, which is expected to be used as a synthetic intermediate for various liquid crystal raw materials or optically active pharmaceuticals and agricultural chemicals.
The enantiomer ester of methylalkanoic acid and the optically active α-methylalkanoic acid represented by the general formula (III) can be efficiently produced regioselectively with high optical purity.

───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.6 識別記号 庁内整理番号 FI 技術表示箇所 (C12P 41/00 C12R 1:19) (C12P 7/24 C12R 1:19) (C12P 7/24 C12R 1:38) (C12P 7/40 C12R 1:38) (C12P 7/40 C12R 1:19) ─────────────────────────────────────────────────── ─── Continuation of the front page (51) Int.Cl. 6 Identification code Internal reference number FI Technical indication (C12P 41/00 C12R 1:19) (C12P 7/24 C12R 1:19) (C12P 7/24 C12R 1:38) (C12P 7/40 C12R 1:38) (C12P 7/40 C12R 1:19)

Claims (4)

【特許請求の範囲】[Claims] 【請求項1】 下記の一般式(I): 【化1】 で表されるラセミ体α−メチルアルカン酸エステルに、
エステル結合を不斉加水分解する能力を有する微生物の
培養物、菌体又は菌体処理物を作用させて下記の一般式
(II): 【化2】 で表される光学活性α−メチルアルカン酸、及び/又は
下記の一般式(III): 【化3】 で表される、前記光学活性α−メチルアルカン酸の対掌
体エステルを製造する方法。
1. The following general formula (I): In the racemic α-methylalkanoic acid ester represented by
The following general formula (II): [Chemical Formula 2] is obtained by reacting a culture, a microbial cell or a treated product of a microorganism having the ability to asymmetrically hydrolyze an ester bond. An optically active α-methylalkanoic acid represented by and / or the following general formula (III): The method for producing the enantiomer ester of the optically active α-methylalkanoic acid represented by:
【請求項2】 エステル結合を不斉加水分解する能力を
有する微生物がリパーゼ、プロテアーゼ又はエステラー
ゼを生産する能力を有する微生物であることを特徴とす
る請求項1の光学活性α−メチルアルカン酸、及び/又
はその対掌体エステルを製造する方法。
2. The optically active α-methylalkanoic acid according to claim 1, wherein the microorganism capable of asymmetrically hydrolyzing an ester bond is a microorganism capable of producing lipase, protease or esterase, and / Or a method for producing an antipodal ester thereof.
【請求項3】 エステル結合を不斉加水分解する能力を
有する微生物がシュードモナス(Pseudomonas)属又はエ
セリキア(Escherichia)属に属する微生物であることを
特徴とする請求項1の光学活性α−メチルアルカン酸、
及び/又はその対掌体エステルを製造する方法。
3. The optically active α-methylalkanoic acid according to claim 1, wherein the microorganism having the ability to asymmetrically hydrolyze an ester bond is a microorganism belonging to the genus Pseudomonas or the genus Escherichia. ,
And / or a method for producing an antipodal ester thereof.
【請求項4】 エステル結合を不斉加水分解する能力を
有する微生物が、エステル結合を不斉加水分解する酵素
をコードする遺伝子により形質転換された遺伝子操作微
生物であることを特徴とする請求項1の光学活性α−メ
チルアルカン酸、及び/又はその対掌体エステルを製造
する方法。
4. The microorganism having the ability to asymmetrically hydrolyze ester bonds is a genetically engineered microorganism transformed with a gene encoding an enzyme that asymmetrically hydrolyzes ester bonds. Of the optically active α-methylalkanoic acid, and / or an enantiomer ester thereof.
JP21894195A 1995-08-28 1995-08-28 Production of optically active alpha-methylalkanoic acid derivative Pending JPH0965891A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP21894195A JPH0965891A (en) 1995-08-28 1995-08-28 Production of optically active alpha-methylalkanoic acid derivative

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP21894195A JPH0965891A (en) 1995-08-28 1995-08-28 Production of optically active alpha-methylalkanoic acid derivative

Publications (1)

Publication Number Publication Date
JPH0965891A true JPH0965891A (en) 1997-03-11

Family

ID=16727735

Family Applications (1)

Application Number Title Priority Date Filing Date
JP21894195A Pending JPH0965891A (en) 1995-08-28 1995-08-28 Production of optically active alpha-methylalkanoic acid derivative

Country Status (1)

Country Link
JP (1) JPH0965891A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005348727A (en) * 2004-05-12 2005-12-22 T Hasegawa Co Ltd Method for producing (r)-2-methyllactic acid and (r)-2-methylpentanoic acid

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005348727A (en) * 2004-05-12 2005-12-22 T Hasegawa Co Ltd Method for producing (r)-2-methyllactic acid and (r)-2-methylpentanoic acid
JP4656636B2 (en) * 2004-05-12 2011-03-23 長谷川香料株式会社 Process for producing (R) -2-methylbutyric acid and (R) -2-methylpentanoic acid

Similar Documents

Publication Publication Date Title
EP0195717B1 (en) Process for the biotechnological preparation of optically active alpha-arylalkanoic acids
JP4189032B2 (en) Biological resolution of N-acylazetidine-2-carboxylic acid
EP0765857B1 (en) Process for producing optically active alpha-substituted carboxylic acid derivatives
US5658796A (en) Optical resolution of alkyl chroman-2-carboxylates
JP3732535B2 (en) Process for producing optically active α-methylalkanedicarboxylic acid-ω-monoester and its enantiomer diester
JPH0965891A (en) Production of optically active alpha-methylalkanoic acid derivative
JPH10136995A (en) Production of optically active 3-quinuclidinol derivative
JPH1014590A (en) Production of optically active 2-substituted-3-phenylpropionic acid and its ester
JP3970898B2 (en) Process for producing optically active α-methylalkanedicarboxylic acid-ω-monoester and its enantiomer diester
JPS63245694A (en) Production of optically active sulfur-containing carboxylic acid and antipodal ester thereof
JPS62272983A (en) Production of l-(-)-carnitine chloride starting from 3, 4-epoxybutyric ester
JP2639651B2 (en) Process for producing optically active carboxylic acid and its enantiomer ester
US5248601A (en) Process for preparing L(-)-carnitine chloride
JPH0959217A (en) New optically active halogen-containing carboxylic acid derivative and its production
JP4565672B2 (en) Optically active β-cyanoisobutyric acid and process for producing the same
JP3715662B2 (en) Process for producing optically active β-hydroxycarboxylic acid and its enantiomer ester
JPH0959211A (en) New optically active dicarboxylic acid derivative and its production
JP3217301B2 (en) Method for producing optically active glycidic acid ester and optically active glyceric acid ester
JPH0573396B2 (en)
JP4746019B2 (en) Optically active β-cyanoisobutyric acid and process for producing the same
JP4392812B2 (en) Novel optically active 4-amino-2-methylbutyric acid derivative and method for producing the same
JP3960667B2 (en) β-carbamoylisobutyric acid and process for producing the same
JPH10287620A (en) Optically active methylsuccinic ester, and its production
JPH08259500A (en) New optically active unsaturated carboxylic acid derivative and its production
JPH0779711B2 (en) Method for producing indoline-2-carboxylic acid by optical resolution

Legal Events

Date Code Title Description
A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20040713

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20040907

A131 Notification of reasons for refusal

Effective date: 20050412

Free format text: JAPANESE INTERMEDIATE CODE: A131

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20050603

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20050719